Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CAPR |
---|---|---|
09:32 ET | 2228 | 3.61 |
09:34 ET | 100 | 3.62 |
09:41 ET | 800 | 3.66 |
09:45 ET | 200 | 3.67 |
09:52 ET | 600 | 3.68 |
09:56 ET | 6325 | 3.65 |
10:01 ET | 100 | 3.67 |
10:06 ET | 490 | 3.6415 |
10:15 ET | 1405 | 3.69 |
10:19 ET | 100 | 3.69 |
10:24 ET | 438 | 3.72 |
10:32 ET | 2000 | 3.7338 |
10:33 ET | 1200 | 3.7246 |
10:35 ET | 2333 | 3.78 |
10:37 ET | 200 | 3.74 |
10:39 ET | 100 | 3.77 |
10:44 ET | 600 | 3.77 |
10:46 ET | 313 | 3.74 |
10:55 ET | 1000 | 3.7225 |
10:57 ET | 100 | 3.75 |
11:00 ET | 100 | 3.73 |
11:02 ET | 511 | 3.75 |
11:18 ET | 100 | 3.77 |
11:31 ET | 200 | 3.73 |
11:47 ET | 100 | 3.71 |
11:54 ET | 100 | 3.75 |
11:58 ET | 100 | 3.75 |
12:00 ET | 100 | 3.75 |
12:20 ET | 800 | 3.765 |
12:27 ET | 800 | 3.8 |
12:39 ET | 5455 | 3.77 |
12:43 ET | 200 | 3.75 |
12:50 ET | 800 | 3.7305 |
12:57 ET | 100 | 3.73 |
01:08 ET | 300 | 3.755 |
01:12 ET | 300 | 3.73 |
01:14 ET | 3400 | 3.74 |
01:15 ET | 2860 | 3.785 |
01:17 ET | 1300 | 3.81 |
01:19 ET | 2000 | 3.77 |
01:21 ET | 3666 | 3.77 |
01:24 ET | 3500 | 3.75 |
01:26 ET | 7328 | 3.77 |
01:28 ET | 1320 | 3.74 |
01:30 ET | 5000 | 3.745 |
01:37 ET | 600 | 3.7564 |
01:44 ET | 10298 | 3.69 |
01:53 ET | 100 | 3.75 |
02:00 ET | 400 | 3.71 |
02:08 ET | 100 | 3.745 |
02:13 ET | 500 | 3.77 |
02:15 ET | 100 | 3.73 |
02:18 ET | 180 | 3.73 |
02:29 ET | 100 | 3.73 |
02:44 ET | 100 | 3.73 |
02:47 ET | 500 | 3.77 |
03:21 ET | 100 | 3.69 |
03:27 ET | 120 | 3.715 |
03:30 ET | 200 | 3.69 |
03:32 ET | 300 | 3.69 |
03:43 ET | 679 | 3.71 |
03:48 ET | 5199 | 3.715 |
03:50 ET | 100 | 3.715 |
03:52 ET | 953 | 3.73 |
03:54 ET | 954 | 3.73 |
03:57 ET | 300 | 3.7 |
03:59 ET | 2816 | 3.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Capricor Therapeutics Inc | 90.7M | -3.9x | --- |
Candel Therapeutics Inc | 91.0M | -2.5x | --- |
Xilio Therapeutics Inc | 91.2M | -1.1x | --- |
Anixa Biosciences Inc | 91.4M | -5.8x | --- |
Eliem Therapeutics Inc | 91.9M | -1.8x | --- |
Galectin Therapeutics Inc | 87.9M | -2.6x | --- |
Capricor Therapeutics, Inc. is a biotechnology company that is focused on developing transformative cell and exosome-based therapeutics and vaccines for treating and preventing a broad spectrum of diseases. The Company consists of cell therapy program, including CAP-1002 for Duchenne Muscular Dystrophy program and CAP-1002 with CAP-1002 for coronavirus (COVID-19). The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is in clinical development for treating Duchenne muscular dystrophy and the cytokine storm associated with COVID-19. Capricor is also developing its exosome technology therapeutic platform. The Company is focused on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA) as well as proteins, to treat or prevent a range of diseases. CAP-1002 cell therapy programs initiated Pivotal Phase III, HOPE-3.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $90.7M |
---|---|
Revenue (TTM) | $204.1K |
Shares Outstanding | 24.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 5.12 |
EPS | $-0.96 |
Book Value | $1.30 |
P/E Ratio | -3.9x |
Price/Sales (TTM) | 444.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -11,416.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.